Loading...
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias
There is no standard or widely effective treatment of patients with moderate aplastic anemia (MAA) or hypo-productive uni-lineage cytopenias (UC). Eltrombopag (EPAG), a small molecule thrombopoietin mimetic, has previously been shown to result in durable multi-lineage hematologic responses with low...
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7189303/ https://ncbi.nlm.nih.gov/pubmed/32330244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001657 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|